Extracorporeal fibrinogen adsorption - Efficacy, selectivity and safety in healthy subjects and patients with foot ulcers

Transfusion and Apheresis Science

Volumn 26, Issue 1, 2002, Pages 15-27

  Richter, Werner O ^a   Schneidewind, Jana Marie ^b   Ramlow, Wolfgang ^b   Jahn, Peter ^c   Jung, Norbert ^d   Nielebock, Evelyn ^e   Tachezy, Hauke ^f   Eulitz, Klaus ^g   Koll, Robert ^g   Klinkmann, Jens ^g  

^a Institute for Lipid Metabolism and Hemorheology   (Germany)

^b Dialysis Group North   (Germany)

^c Dialysis Center   (Germany)

^d Dialysis Center   (Germany)

^e Dialysis Center   (Germany)

^f Dialysis Center   (Germany)

^g PlasmaSelect AG   (Germany)

Author keywords

Apheresis; Blood viscosity; Extracorporeal adsorption; Fibrinogen; Foot ulcer

Indexed keywords

FIBRINOGEN; GLY PRO ARG PRO LYS; PENTAPEPTIDE; UNCLASSIFIED DRUG; GLYCYL PROLYL ARGINYL PROLYL LYSYL FRACTOGEL; GLYCYL-PROLYL-ARGINYL-PROLYL-LYSYL-FRACTOGEL; OLIGOPEPTIDE; POLYMER; SEPHAROSE;

AFFINITY CHROMATOGRAPHY; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOOT ULCER; HEMODIALYSIS; HUMAN; HUMAN TISSUE; MALE; PLASMA VISCOSITY; TREATMENT OUTCOME; WOUND HEALING; ADOLESCENT; ADULT; AGED; BLOOD; BLOOD VISCOSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC FOOT; EXTRACORPOREAL CIRCULATION; HEMOPERFUSION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STANDARD;

ADOLESCENT; ADULT; AGED; BLOOD COMPONENT REMOVAL; BLOOD VISCOSITY; CHROMATOGRAPHY, AFFINITY; DIABETIC FOOT; EXTRACORPOREAL CIRCULATION; FEMALE; FIBRINOGEN; FOOT ULCER; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; POLYMERS; SENSITIVITY AND SPECIFICITY; SEPHAROSE; TREATMENT OUTCOME;

EID: 0035991902     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(01)00140-9     Document Type: Article

References (32)

1. Plasma viscosity in 615 subjects. Effects of fibrinogen, globulin, and cholesterol in normals, peripheral vascular disease, retinopathy, and melanoma
2. Whole blood viscosity parameters and cerebral blood flow
3. Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease
4. Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP)
5. Extracorporeal membrane differential filtration - a new and safe method to optimize hemorheology in acute ischemic stroke
6. Treatment of severe hypercholesterolemia with heparin-induced LDL apheresis
7. Hemorheological parameters during extracorporeal LDL elimination by immunabsorption and HELP
8. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation
9. Contribution of plasma constituents to plasma viscosity, in-vitro evaluation by column depletion of low-density-lipoproteins, fibrinogen, or immunoglobulins
10. Isolation of human fibrinogen and its derivatives by affinity chromatography on gly-pro-arg-pro-lys-fractogel
11. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites and species differences
12. Amino acids and peptides. XVII. Synthesis of peptides related to N-terminal portion of fibrin α-chain and their inhibitory effect on fibrinogen/thrombin clotting
13. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl erster transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase acitivity in type IIb hyperlipoproteinaemia
14. Effect of three fibrate derivatives and two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia
15. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia
16. Defibrinogenating enzymes
17. 2 reactivity during hypercapnia in normal subjects
18. Blood and plasma viscosity in experimentally induced hyper- and hypo-fibrinogenaemia
19. Blood flow resistance during hemodilution: effect of plasma composition
20. Treatment of patients with peripheral arterial occlusive disease Fontaine stage III and IV with intravenous iloprost: an open study in 900 patients
21. Ultrastructural basis of the mechanism of rouleaux formation
22. Effect of low fibrinogen concentrations on the rheology of human blood in vitro
23. The relationship of plasma fibrinogen, erythrocyte flexibility and blood viscosity
24. Do physiological concentrations of IgG induce a direct aggregation of red blood cells: comparison with fibrinogen
25. Relation of the viscosity of plasma and whole blood
26. The fibrinolytic system and its relation to inflammatory disease
27. Participation of components of the blood coagulation system in the inflammatory response
28. Function of C-reactive protein
29. Impediments to wound healing
30. Management of ischemic heel ulceration and gangrene: An evaluation of factors associated with successful healing